Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (1)
  • 2023 (1)
  • 2022 (7)
  • 2021 (2)

Subject

  • Prescription Drugs (9)
  • Diversion Division (8)
  • Pharmaceuticals/Pharmacists/Physicians (8)
  • Drug Trafficking (6)
  • Seizures (Drugs/Property) (6)
  • Synthetic drugs (6)
  • Major Law Enforcement Operation (4)
  • Task Forces/Task Force Officers (4)
  • Overdose (3)
  • Arrests/Convictions - Major (1)
  • Dark Web- Internet Trafficking (1)
  • Fake Pills (1)
  • Museum and Visitors Center (1)
  • Public and Media Affairs - also see Congressional Affairs (1)

Drug Name

  • Fentanyl (405)
  • Methamphetamine (307)
  • Heroin (219)
  • Cocaine (198)
  • Synthetic Opioids (84)
  • Opioids (63)
  • Oxycodone (38)
  • Marijuana (Cannabis) (29)
  • Benzodiazepines (10)
  • Ecstasy/MDMA (8)
  • Morphine (7)
  • Steroids (6)
  • K2/Spice (5)
  • Methadone (4)
  • Amphetamines (3)
  • Ketamine (3)
  • Marijuana Concentrates (3)
  • Synthetic Bath Salts or Designer Cathinones (3)
  • Xylazine (1)
  • Hydromorphone (12)

Field Division

  • Atlanta (7)
  • Miami (6)
  • New England (5)
  • St. Louis (3)
  • Dallas (1)
  • New York (1)
  • San Diego (1)
  • Washington, DC (7)
  • Seattle (5)
Clear All Results
PRESS RELEASE

UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

Julio 01, 2025
SEATTLE, Wash.--Dr. Andrew Voegel-Podadera, 35, a resident physician at the University of Washington Medical School who worked at Seattle Children’s Hospital, UW Medicine, and Harborview Medical Center is charged with two counts of Acquiring a Controlled Substance by Misrepresentation, Fraud, Deception, and Subterfuge. On June 24th, 2025, DEA Seattle Diversion...
Julio 01, 2025
PRESS RELEASE

Hospital in Washington Agrees to Pay $15,000 Penalty and Implement Corrective Actions to Address Theft of Controlled Substances

Noviembre 18, 2024
Spokane, Wash. - Mid-Valley Hospital and Clinic in Omak, Washington, agreed to pay a $15,000 Controlled Substances Act penalty and to institute corrective actions in regard to its pharmacy and controlled substances policy and procedures. To protect the public, the Controlled Substances Act and its implementing regulations place legal responsibilities...
Noviembre 18, 2024
PRESS RELEASE

Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths

Junio 16, 2023
ANCHORAGE, ALASKA—Former Advanced Nurse Practitioner Jessica Joyce Spayd (52) was sentenced in U.S. District Court yesterday to 30 years (360 months) imprisonment for illegally prescribing and dispensing opioids outside the scope of legitimate medical practice that resulted in the deaths of five people between 2014 and 2019. United States District...
Junio 16, 2023
PRESS RELEASE

Drug Dealing Husband and Wife Sentenced to Federal Prison

Noviembre 29, 2022
EUGENE, Ore.—A Douglas County couple known for distributing drugs was sentenced to federal prison today after they were linked to the overdose death of man to whom they had sold drugs to for more than a year. Brian Joseph Ramos, 49, and Christine Marie Ramos, 41, residents of Yoncalla, Oregon...
Noviembre 29, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

Abril 28, 2022
SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
Abril 28, 2022
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

Marzo 04, 2022
DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
Marzo 04, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

Enero 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man, and former veterinarian, pleaded guilty to a pair of drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to the adulteration of a drug held...
Enero 24, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

Enero 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
Enero 24, 2022
Showing 1 - 10 of 12 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster